These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 25735349)

  • 1. Malignant transformation rate and p53, and p16 expression in teratomatous skin of ovarian mature cystic teratoma.
    Zhu HL; Zou ZN; Lin PX; Li WX; Huang YE; Shi XX; Shen H
    Asian Pac J Cancer Prev; 2015; 16(3):1165-8. PubMed ID: 25735349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
    Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
    Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Frequency of Malignant Transformation of Ovarian Mature Teratoma into Squamous Cell Carcinoma in Young Patients in Northeast Brazil.
    Araujo IB; Pinheiro MV; Zanvettor PH; Studart EJ; Filho DF; Coupland SE
    Int J Gynecol Pathol; 2016 Mar; 35(2):176-84. PubMed ID: 26367783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant Transformation of Mature Cystic Teratoma: Is Squamous Cell Carcinoma Different From the Other Types of Neoplasm?
    Akazawa M; Onjo S
    Int J Gynecol Cancer; 2018 Nov; 28(9):1650-1656. PubMed ID: 30358706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclooxygenase-2 in ovarian mature cystic teratomas with malignant transformation.
    Sumi T; Ishiko O; Yoshida H; Hyun Y; Nakagawa E; Hirai K; Matsumoto Y; Ogita S
    Int J Mol Med; 2001 Nov; 8(5):495-8. PubMed ID: 11605016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and molecular studies on malignant transformation in mature cystic teratoma of the ovary.
    Yoshioka T; Tanaka T
    J Obstet Gynaecol Res; 1998 Apr; 24(2):83-90. PubMed ID: 9631595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of 44 cases with malignant transformation of ovarian mature cystic teratoma].
    An JS; Wu LY; Li XG; Zhang R; Song Y; Ma SK; Liu LY; Hong WJ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):123-8. PubMed ID: 23544494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mature cystic ovarian teratoma with squamous cell carcinoma transformation: a case report and literature review.
    Abdoli Shadbad M; Derogar R; Shekarchi AA; Akbari F; Jafari Shobeiri M
    Horm Mol Biol Clin Investig; 2024 Mar; 45(1):35-39. PubMed ID: 38282269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution.
    Oranratanaphan S; Khemapech N
    Asian Pac J Cancer Prev; 2013; 14(8):4693-7. PubMed ID: 24083728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53, p16 and Ki67 immunoexpression in cutaneous squamous cell carcinoma and its precursor lesions.
    Marinescu A; Stepan AE; Mărgăritescu C; Marinescu AM; Zăvoi RE; Simionescu CE; Niculescu M
    Rom J Morphol Embryol; 2016; 57(2 Suppl):691-696. PubMed ID: 27833960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma and pleomorphic sarcoma (MFH) arising in a mature cystic teratoma of the ovary.
    Savitchi E; Rao S
    Int J Gynecol Pathol; 2012 Sep; 31(5):443-6. PubMed ID: 22833084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
    Lu DW; El-Mofty SK; Wang HL
    Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Squamous cell carcinoma in situ arising in ovarian mature cystic teratoma].
    Gurrera A; Brancato F; Puzzo L; Magro G; Greco P
    Pathologica; 2008 Feb; 100(1):9-12. PubMed ID: 18686519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
    Cai S; Han K
    J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
    Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
    J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma arising in mature cystic teratoma with sigmoid invasion.
    Srivastava P; Dawson L; Mandal AK
    J Cancer Res Ther; 2015; 11(4):1024. PubMed ID: 26881587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation from mature cystic teratoma of the ovary.
    Shimada T; Higashijima A; Fukushima A; Komatsu N; Noguchi M; Ohashi K; Hasegawa Y; Miura K
    J Obstet Gynaecol Res; 2019 Sep; 45(9):1957-1960. PubMed ID: 31215124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A challenging question for gynecologic oncologists.
    Gadducci A; Guerrieri ME; Cosio S
    Crit Rev Oncol Hematol; 2019 Jan; 133():92-98. PubMed ID: 30661663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Transformation in Mature Cystic Teratomas of the Ovary: Case Reports and Review of the Literature.
    Gadducci A; Pistolesi S; Guerrieri ME; Cosio S; Carbone FG; Naccarato AG
    Anticancer Res; 2018 Jun; 38(6):3669-3675. PubMed ID: 29848726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.